AI-Driven Discovery and Next-Gen Therapeutic Platforms Lead This Week’s Biotech Funding | Biotech Venture Deals This Week | VentureRadar AI-Driven Discovery and Next-Gen Therapeutic Platforms Lead This Week’s Biotech Funding | Biotech Venture Deals This Week

🧬 Weekly biotech funding roundup: investors back AI-driven discovery, genetic medicine delivery, and next-gen diagnostics.

Examples include Antiverse, Outpost Bio, TileBio, GenEdit, Xsensio, and BrainCheck.

Full breakdown → www.ventureradar.com/articles/AI-...

#Biotech #AIinBiotech

Phase 1 dosing milestone for MEN2501 signals growing confidence in generative AI drug discovery and its healthspan implications.

vist.ly/4qmpn

#longevity #AIinBiotech #drugdiscovery #clinicalmilestone #healthspan #insilicomedicine

GPT-5 Achieves 40% Cost Reduction in Protein Synthesis Through Autonomous Laboratory Testing Quick Brief GPT-5 reduced protein production costs from $698 to $422 per gram in six experimental rounds Autonomous lab tested 36,000+ reactions across 580 automated plates over two months System achieved 57% improvement in reagent costs through novel composition discovery Breakthrough demonstrates AI's capacity to optimize complex biological processes autonomously OpenAI's GPT-5 has achieved a 40% reduction in cell-free protein synthesis costs by autonomously designing and executing over 36,000 laboratory experiments.

GPT-5 slashes protein production costs 40% in autonomous lab breakthrough $422/gram vs $698. OpenAI + Ginkgo Bioworks tested 36,000+ reactions to transform drug discovery economics. AdwaitX breaks down what it means for biotech #AdwaitX #GPT5 #AIinBiotech #AI

Insilico Medicine and Qilu Pharmaceutical team up to fast-track AI-designed drugs tackling heart, metabolism and aging-related diseases.

longevity.technology/news/120m-pa...

#AIinBiotech #Cardiometabolic #InsilicoMedicine #QiluPharma #PrecisionTherapy #longevity #HealthTech #DrugDiscovery

Protein design is no longer a linear process.
AI enables prediction, generation, optimization, and iteration — all in one workflow.

That’s how discovery cycles get shorter, smarter, and more scalable.

#AIinBiotech #ProteinEngineering #DrugDiscovery #ComputationalBiology #LifeSciences #DeepTech

Insilico Medicine IPO signals that AI‑native drug discovery is moving from promise to public markets with a central longevity narrative.

longevity.technology/news/insilic...

#longevity #AIinBiotech #DrugDiscovery #BiotechIPO #CapitalMarkets #DeepTech #LifeSciences

An end-of-year experiment exploring how large language models perceive leadership in AI-driven longevity.

longevity.technology/news/asking-...

#longevity #AI #AIforHealth #AIinBiotech #Leadership #FutureOfAging #TechTrend

Measure trust, not hype. 🤖
Masaki Yamada (@invert) shows how to quantify AI confidence in biotech.
🎧 Full AI Thought Leaders ep drops Sun 7 AM PST: youtube.com/@HelicalBrew

#HelicalBrew #AIThoughtLeaders #AIinBiotech #LabAutomation

Hallucinations are good… sometimes? 👀
Masaki Yamada (@invert) on why creativity belongs in brainstorming - not in your data.
🎧 Full AI Thought Leaders episode drops Sun 7 AM PST: youtube.com/@HelicalBrew

#HelicalBrew #AIThoughtLeaders #AIinBiotech #LabAutomation

Dr. Kai Hilpert | AI-Powered Prediction of Antimicrobial Peptides in Human Serum: A New Strategy Against Resistant Bacteria • scipod.global In the 20th century, antibiotics transformed medicine. Infections that once killed millions could be cured with a pill or injection. Surgeries became safer, cancer treatments more effective, and advan...

Dr Kai Hilpert’s team is using AI to predict antimicrobial peptides in human serum, unveiling a powerful new strategy against antibiotic-resistant bacteria.
www.scipod.global/dr-kai-hilpe... #AMR #AIinBiotech

Exploring fibrous proteins, elastin & mucins: structure, apps & AI-driven design for biomedicine & industry. #ProteinScience #AIinBiotech
Details: doi.org/10.1016/j.bidere.2025.100004

🧬 At Delta4, we turn omics data into actionable insights. By integrating multi-omics layers into our Hyper-C platform, we simulate disease mechanisms, predict drug responses, and uncover new indications — advancing precision drug repositioning for complex and rare diseases.
#AIinBiotech

Precision Therapies and AI-Driven Discovery Dominate This Week’s Deals | Biotech VC Deals Weekly Roundup | VentureRadar Precision Therapies and AI-Driven Discovery Dominate This Week’s Deals | Biotech VC Deals Weekly Roundup

🧬 Biotech VC Roundup: Precision therapies & AI-driven discovery lead deals. Trends: neurodegeneration, gene writing & liquid biopsy. Spotlight: Alchemab, iRegene, Integra, ArcaScience.

Read more → www.ventureradar.com/articles/Pre...

#Biotech #VC #AIinBiotech #DrugDiscovery #GeneTherapy

Synapse: Your Connection to our MSK Authors
Meet: Paul A Calder
Research Focus: SKI Pediatrics; Sr Research Assistant

synapse.mskcc.org/synapse/work...

#DrugDiscovery #CombinationTherapy #BayesianModeling #ActiveLearning #AIInBiotech #CancerResearch #PrecisionOncology #SystemsPharmacology

Generative AI models build new antibiotics starting from a single atom Researchers have tapped into the power of generative artificial intelligence to aid them in the fight against one of humanity’s most pernicious foes: antibiotic-resistant bacteria. | Researchers have tapped into the power of generative artificial intelligence to aid them in the fight against one of humanity’s most pernicious foes: antibiotic-resistant bacteria. Using a model trained on a library of about 40,000 chemicals, scientists were able to build never-before-seen antibiotics that killed two of the most notorious multidrug-resistant bacteria on earth.

Can generative AI revolutionize antibiotic discovery? Researchers believe it can. Explore this innovation in combatting bacterial resistance! #AIinBiotech

www.fiercebiotech.com/research/deep-learning-g...

Biotech in 2025: Where AI Meets Life Itself | Rajesh Menon Biotech in 2025: Where AI Meets Life Itself /* Latest Developments: From CRISPR to Living Medicines How AI Is Accelerating Biotech Examples of AI in Action The Future: Technospirituality Meets...

Biotech in 2025 Where AI Meets Life Itself
tinyurl.com/2bxxqbmy

#Biotech #CRISPR #AIinBiotech #BioIntelligence #technospirituality #rajesh30menon #TechCareers #monday

Respiratory Weekly News – July 18th 2025 Respiratory & Pulmonary Health Updates: PAH Approval, CF Gene Editing, IPF Breakthroughs & More 🫁💡 In this week’s Respiratory and […] The post Respiratory Weekly News – July 18th 2025 appeared first on LucidQuest Ventures.

FYI: LucidQuest Views >>> Respiratory Weekly News – July 18th 2025 #News #AIinBiotech #CFResearch #COPDTreatment Comment below!

Respiratory Weekly News – July 18th 2025 Respiratory & Pulmonary Health Updates: PAH Approval, CF Gene Editing, IPF Breakthroughs & More 🫁💡 In this week’s Respiratory and […] The post Respiratory Weekly News – July 18th 2025 appeared first on LucidQuest Ventures.

ICYMI: LucidQuest Views >>> Respiratory Weekly News – July 18th 2025 #News #AIinBiotech #CFResearch #COPDTreatment Comment below!

Respiratory Weekly News – July 18th 2025 Respiratory & Pulmonary Health Updates: PAH Approval, CF Gene Editing, IPF Breakthroughs & More 🫁💡 In this week’s Respiratory and […] The post Respiratory Weekly News – July 18th 2025 appeared first on LucidQuest Ventures.

LucidQuest Views >>> Respiratory Weekly News – July 18th 2025 #News #AIinBiotech #CFResearch #COPDTreatment Comment below!

AI protein design could spawn 'impossible' enzymes that eat plastic faster than we produce it. What's the unintended side‑effect we aren't seeing?

#ProteinDesign
#AIinBiotech
#Biodegradation

Translational Omics for Therapeutic Breakthroughs with Benthos YouTube video by Life Science Insights360

🚀 From RNA biology to AI-driven drug discovery — at Benthos, we tackle hard biological problems, not just analyze data.

🎙️ CEO Dr. Prabhu Mathiyalagan spoke with Life Science Insights 360 about our mission.

🎥 Watch: www.youtube.com/watch?v=SG8L...

#Omics #AIinBiotech #RNA #Biotech

Atoms, Algorithms, and Answers: Where Science Is Headed Next - WIOBS From quantum leaps to AI breakthroughs, modern science is redefining our future by merging physics, data, and deep discovery

Atoms, Algorithms, and Answers: Where Science Is Headed Next wiobs.com/atoms-algori... #FutureOfScience #QuantumComputing #AIinBiotech #FusionEnergy

2nd Single Cell Congress: Asia Hong Kong 10 - 11 July 2025

🎟️ 𝐆𝐫𝐚𝐛 𝐘𝐨𝐮𝐫 𝐅𝐫𝐞𝐞 𝐏𝐚𝐬𝐬 𝐓𝐨𝐝𝐚𝐲!
🔬 Explore cutting-edge advances in #SingleCellGenomics, #Transcriptomics & #Proteomics at the 𝟐𝐧𝐝 𝐒𝐢𝐧𝐠𝐥𝐞 𝐂𝐞𝐥𝐥 𝐂𝐨𝐧𝐠𝐫𝐞𝐬𝐬 𝐀𝐬𝐢𝐚 – 𝐃𝐨𝐧’𝐭 𝐌𝐢𝐬𝐬 𝐎𝐮𝐭!

🔗𝐀𝐩𝐩𝐥𝐲 𝐧𝐨𝐰: lnkd.in/gFA6p5Ai

#SingleCellAsia2025 #MultiOmics #PrecisionMedicine #AIinBiotech #CancerResearch #GlobalEngage

Excited to be speaking at BTBA 2025 at Harvard, where I’ll share our recent work on SystemsAge—an AI-driven tool for measuring organ-level aging.

#BTBA2025 #SystemsAge #LongevityScience #PrecisionAging #AIinBiotech #HealthyLongevity #HarvardEvents

✅ Match model to task
✅ Keep cost and security in check
✅ Iterate fast

At Elucidata, we help teams do just that - without needing an LLM lab.

Get in touch with us if this excites you.

#AIinBiotech #GenAI #LifeSciencesAI

What It Looks Like to Industrialize Antibody Developability Assays A proof of what becomes possible when assay platforms are built with AI-scale data generation in mind.

Most AI antibody papers talk models. This one talks infrastructure.

Ginkgo’s PROPHET-Ab platform runs real assays, at scale, upstream, and cleanly. But can it handle messy, early-stage variants?

medium.com/@enginyapici...

#DrugDevelopment #AIinBiotech #Antibodies #DrugDiscovery #Biologics #AI

We use generative AI to create DesignerBodies™ — custom affinity reagents for real-world use 🧪
What people loved most: we don’t just design, we deliver.

Learn more: www.affinityai.org

#AIinBiotech #ProteinDesign

AI Engineers DNA to Control Genes in Living Cells Scientists at the Centre for Genomic Regulation have used AI to create synthetic DNA that can control genes in living cells, offering unprecedented precision for gene therapy and synthetic biology.

AI-designed DNA now controls genes in living cells—unlocking a new era of targeted gene therapies. #SyntheticBiology #GeneticEngineering #AIinBiotech

Can an AI-identified drug duo change the game for FSGS? 💊
Saroglitazar + Myristic Acid showed strong synergy in preclinical models—tackling fibrosis, inflammation & more. A promising step for rare kidney disease patients.

#FSGS #AIinBiotech #DrugRepurposing #RareDisease

What we offer:
– Designerbodies™ with pM–nM affinity
– ARCANE™ designs for affinity, stability, and expression
– RAVEN™ screens candidates at scale
Built for diagnostics, therapeutics, and biotech pipelines.
#AIinBiotech #SyntheticBiology